Showing results (231-240 of 523) with videos related to

Sort By:
Pageof 53
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 29, 2005
Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathiesPedro Aranda, Julian Segura, Luis M Ruilope, et al.
American Journal of Hypertension|September 25, 2013
Nocturnal hypertension or nondipping: which is better associated with the cardiovascular risk profile?Alejandro de la Sierra, Manuel Gorostidi, José R Banegas, et al.
Journal of the American Society of Nephrology : JASN|December 20, 2003
Hypertensive renal damage in metabolic syndrome is associated with glucose metabolism disturbancesJulián Segura, Carlos Campo, Cecilia Roldán, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 8, 2025
Mortality according to ambulatory blood pressure in hypertensive patients with normal or impaired kidney functionManuel Gorostidi, Michael Böhm, Luis M Ruilope, et al.
Journal of Hypertension|January 27, 2012
Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?Massimo Volpe, A H Jan Danser, Joël Menard, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|November 10, 2021
Molecular Characterization of Peritoneal Involvement in Primary Colon and Ovary Neoplasm: The Possible Clinical Meaning of the P2X7 Receptor-Inflammasome ComplexAnna Solini, Luigi Cobuccio, Chiara Rossi, et al.
European Journal of Clinical Investigation|December 23, 2017
The level of physical training modulates cytokine levels through P2X7 receptor in healthy subjectsMario Comassi, Eleonora Santini, Chiara Rossi, et al.
Diabetology & Metabolic Syndrome|May 17, 2024
Response to semaglutide of non-drinker subjects with type 2 diabetesGiovanni Petralli, Francesco Raggi, Alice Del Zoppo, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2003
Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT)Giuseppe Mancia, Morris Brown, Alain Castaigne, et al.
Pageof 53